Yi Du

4.9k total citations · 1 hit paper
67 papers, 3.7k citations indexed

About

Yi Du is a scholar working on Molecular Biology, Materials Chemistry and Cancer Research. According to data from OpenAlex, Yi Du has authored 67 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Materials Chemistry and 16 papers in Cancer Research. Recurrent topics in Yi Du's work include Pickering emulsions and particle stabilization (15 papers), Advanced Polymer Synthesis and Characterization (12 papers) and Cancer-related Molecular Pathways (6 papers). Yi Du is often cited by papers focused on Pickering emulsions and particle stabilization (15 papers), Advanced Polymer Synthesis and Characterization (12 papers) and Cancer-related Molecular Pathways (6 papers). Yi Du collaborates with scholars based in China, United States and Taiwan. Yi Du's co-authors include Mien‐Chie Hung, Weiya Xia, Hirohito Yamaguchi, Jennifer L. Hsu, Jung-Mao Hsu, Chia‐Wei Li, Yongkun Wei, Heng‐Huan Lee, Chao‐Kai Chou and Gabriel N. Hortobágyi and has published in prestigious journals such as Nature, Journal of Biological Chemistry and ACS Nano.

In The Last Decade

Yi Du

65 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

2017 768 citations Shiping Jiao, Weiya Xia et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Du China	28	1.8k	1.4k	660	480	429	67	3.7k
Andreas Evdokiou Australia	40	2.1k 1.2×	1.4k 1.0×	563 0.9×	576 1.2×	512 1.2×	100	4.2k
Sung‐Sik Han South Korea	36	1.0k 0.6×	1.4k 1.0×	417 0.6×	189 0.4×	958 2.2×	193	4.1k
Zohreh Amoozgar United States	29	1.4k 0.8×	1.8k 1.3×	491 0.7×	1.6k 3.3×	597 1.4×	51	4.9k
Sung‐Hwan Moon South Korea	39	4.3k 2.5×	1.2k 0.9×	1.5k 2.3×	394 0.8×	439 1.0×	196	7.5k
Hideki Yamaguchi Japan	37	3.1k 1.8×	1.0k 0.8×	769 1.2×	470 1.0×	263 0.6×	86	6.6k
Julia Y. Ljubimova United States	38	2.1k 1.2×	555 0.4×	304 0.5×	312 0.7×	334 0.8×	83	5.0k
In-San Kim South Korea	36	2.1k 1.2×	535 0.4×	520 0.8×	554 1.2×	209 0.5×	68	3.8k
Rang‐Woon Park South Korea	35	2.1k 1.2×	483 0.4×	412 0.6×	296 0.6×	221 0.5×	54	4.6k
Yun Wu United States	40	2.9k 1.7×	886 0.7×	1.2k 1.8×	310 0.6×	257 0.6×	113	5.1k
Masaharu Seno Japan	46	4.1k 2.3×	1.6k 1.2×	654 1.0×	625 1.3×	237 0.6×	238	6.5k

Countries citing papers authored by Yi Du

Since Specialization

Citations

This map shows the geographic impact of Yi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Du more than expected).

Fields of papers citing papers by Yi Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Du. The network helps show where Yi Du may publish in the future.

Co-authorship network of co-authors of Yi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Du. A scholar is included among the top collaborators of Yi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Du. Yi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Chen, Yi Du, Yang Hu, et al.. (2023). A Reconfigurable 2D-Mesh NoC Design with Agile Development Technique of SpinalHDL. 142–145.

Du, Yi, et al.. (2021). Effect of Sanguinarine chloride on proliferation and apoptosis of human tongue cancer cells and its mechanism. Panminerva Medica. 65(1). 104–106. 3 indexed citations

Lin, Qin, et al.. (2020). Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio. BMC Oral Health. 20(1). 27–27. 31 indexed citations

Li, Hui, Chia‐Wei Li, Xiaoqiang Li, et al.. (2019). MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. Gastroenterology. 156(6). 1849–1861.e13. 154 indexed citations

Zhao, Jingjie, Xuesong Gao, Anna Wang, Yongzhi Wang, & Yi Du. (2019). Regulation of Chaihu Shugan Powder on kynurenine in raphe nucleus of depressive rats induced by reserpine. Zhonghua xingwei yixue yu naokexue zazhi. 28(6). 481–486. 1 indexed citations

Chen, Mei‐Kuang, Yi Du, Linlin Sun, et al.. (2019). H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism. Journal of Biological Chemistry. 294(21). 8516–8528. 18 indexed citations

Dong, Qiongzhu, Yi Du, Hui Li, et al.. (2018). EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma. Cancer Research. 79(4). 819–829. 59 indexed citations

Jiao, Shiping, Weiya Xia, Hirohito Yamaguchi, et al.. (2017). PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. Clinical Cancer Research. 23(14). 3711–3720. 768 indexed citations breakdown →

Du, Yi, Katsuya Nakai, Ming Ding, et al.. (2017). EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer. Oncogene. 37(2). 208–217. 83 indexed citations

10.

Wang, Yongzhi, et al.. (2015). Effect of Chaihu Shugan Powder on the content of 5-hydroxytryptamine and the expression of tryptophan hydroxylase 2 in depression rats. Zhonghua xingwei yixue yu naokexue zazhi. 24(5). 407–410. 2 indexed citations

11.

Yamaguchi, Hirohito, Jennifer L. Hsu, Chun‐Te Chen, et al.. (2013). Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non–Small Cell Lung Cancer Cells. Clinical Cancer Research. 19(4). 845–854. 110 indexed citations

12.

Shen, Jia, Weiya Xia, Yekaterina B. Khotskaya, et al.. (2013). EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature. 497(7449). 383–387. 293 indexed citations

13.

Chen, Chun‐Te, Yi Du, Hirohito Yamaguchi, et al.. (2012). Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer. Molecular Cancer Therapeutics. 11(10). 2212–2221. 21 indexed citations

14.

Wang, Ying‐Nai, Heng‐Huan Lee, Hong-Jen Lee, et al.. (2012). Membrane-bound Trafficking Regulates Nuclear Transport of Integral Epidermal Growth Factor Receptor (EGFR) and ErbB-2. Journal of Biological Chemistry. 287(20). 16869–16879. 62 indexed citations

15.

Chen, Chun‐Te, Hirohito Yamaguchi, Hong-Jen Lee, et al.. (2011). Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase. Molecular Cancer Therapeutics. 10(8). 1327–1336. 21 indexed citations

16.

Kang, Kai, Chengyou Kan, Yi Du, & Deshan Liu. (2011). INFLUENCES OF ACID POST-TREATMENT ON THE MORPHOLOGY OF SOAP-FREE P(MMA-EA-MAA) PARTICLES PREPARED BY SEEDED EMULSION POLYMERIZATION. Chinese Journal of Polymer Science. 23(5). 479–485. 1 indexed citations

17.

Cheng, Xiaoyun, Weiya Xia, Jer-Yen Yang, et al.. (2010). Activation of Murine Double Minute 2 by Akt in Mammary Epithelium Delays Mammary Involution and Accelerates Mammary Tumorigenesis. Cancer Research. 70(19). 7684–7689. 16 indexed citations

18.

Yang, Jer-Yen, Chun-Ju Chang, Weiya Xia, et al.. (2010). Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor Chemoresistance in Human Cancer. Cancer Research. 70(11). 4709–4718. 60 indexed citations

19.

Lee, Dung‐Fang, Hsu-Ping Kuo, Mo Liu, et al.. (2009). KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ. Molecular Cell. 36(1). 131–140. 333 indexed citations

20.

Kang, Kai, Chengyou Kan, Yi Du, Deshan Liu, & Anthony Yeung. (2005). Immobilization of aminoglycosidic aminocyclitols antibiotic onto soap-free poly(MMA-EA-AA) latex particles. Journal of Biomaterials Science Polymer Edition. 17(1-2). 91–101. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact